Ikarian Capital’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$316K	Hold	9,717	–	–	0.05%	132
2025 Q4	$342K	Sell	9,717 -283	-3%	-$10K	0.04%	146
2025 Q3	$263K	Sell	10,000 -90,000	-90%	-$2.68M	0.05%	145
2025 Q2	$2.65M	Buy	100,000 +50,000	+100%	+$1.32M	0.88%	57
2025 Q1	$1.21M	Buy	+50,000	New	+$1.58M	0.39%	90
2024 Q3	–	Sell	-138,262	Closed	-$7.33M	–	196
2024 Q2	$7.33M	Buy	+138,262	New	+$9.06M	2.29%	24
2024 Q1	–	Hold	0	–	–	–	199
2023 Q2	–	Sell	-43,156	Closed	-$719K	–	166
2023 Q1	$719K	Sell	43,156 -160,000	-79%	-$1.65M	0.3%	87
2022 Q4	$1.91M	Sell	203,156 -260,000	-56%	-$1.16M	0.79%	42
2022 Q3	$1.26M	Sell	463,156 -372,119	-45%	-$1.22M	0.63%	64
2022 Q2	$2.41M	Buy	835,275 +302,846	+57%	+$749K	1%	52
2022 Q1	$1.6M	Buy	532,429 +31,787	+6%	+$114K	0.49%	78
2021 Q4	$2.3M	Hold	500,642	–	–	0.66%	57
2021 Q3	$3.14M	Sell	500,642 -24,112	-5%	-$149K	0.72%	102
2021 Q2	$3.14M	Sell	524,754 -200,000	-28%	-$1.19M	0.56%	94
2021 Q1	$4.58M	Buy	+724,754	New	+$5.1M	0.68%	125
2020 Q3	–	Sell	-1,159	Closed	-$8K	–	240
2020 Q2	$8K	Sell	1,159 -125,000	-99%	-$830K	﹤0.01%	164
2020 Q1	$590K	Hold	126,159	–	–	0.22%	131
2019 Q4	$1.01M	Buy	+126,159	New	+$920K	0.93%	80